The U.S. Meals and Drug Administration (FDA) has accepted Guardant360 CDx as a companion diagnostic to determine sufferers with BRAF V600E-mutant metastatic colorectal most cancers...
Trendy a number of myeloma therapy usually entails complicated mixture therapies, which considerably impression day by day life for sufferers and care companions. A robust...
Up to date NCCN Medical Apply Tips in Oncology now acknowledge that MammaPrint and BluePrint testing can assist determine a selected subset of hormone receptor...
The metastatic prostate most cancers market is pushed by developments in focused therapies and immunotherapies, catering to a rising ageing inhabitants. Early detection...
The Facilities for Illness Management and Prevention (CDC) at the moment introduced first-year funding awards of $215 million in a 5-year, $1.1 billion...
Printed: July 9, 2024Written by: Beth DoughertyDoctor-scientist Franziska Wachter, MD, got here to Dana-Farber 10 years in the past as a postdoctoral fellow...
